IMEIK responded to the "baby face needle" agency rights dispute: has deemed the other party to be in breach of contract, everything is based on factual and legal grounds
On the evening of July 21, Jiangsu Wuzhong announced that its controlling subsidiary, Datou Medical, received a "Termination Letter" from South Korea's Regen Company on the 18th, unilaterally terminating the exclusive distribution agreement for the "Youthful Needle" product AestheFill in China. Recently, IMEIK completed its acquisition of South Korea's Regen Company. Regarding this termination, Jiangsu Wuzhong stated in a public announcement on the evening of July 21 that the termination letter severely undermines business ethics